The FDA Committees voted against recommending approval of Nektar Therapeutics' oxycodegol.
What are some of the factors affecting whether a brand-name drug has generic competition?
Biosimilar to Remicade
Patients with type 2 diabetes should keep taking their medication.
Removing patient barriers to generic drugs.
Recent approval under new international Project Orbis.
Ultra-rare, potentially life-threatening genetic disease.
Hemoglobin S Polymerization inhibitor oral treatment.
Expected U.S. launch in 2023.
First and currently only biological targeting P-selectin.